Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2024) 144 (Supplement 1): 3030.

https://doi.org/10.1182/blood-2024-198992

Published: 2024

Journal Articles

Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3058.

https://doi.org/10.1182/blood-2024-198371

Published: 2024

Journal Articles

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

Ayumi Fujimoto, Kana Miyazaki, Takeshi Maeda, Kimikazu Yakushijin, Wataru Munakata, Takahiro Fujino, Yasuo Ejima, Nobuhiro Hiramoto, Noriko Fukuhara, Jun Takizawa, Dai Maruyama, Nobuko Kubota, Hideki Goto, Rika Sakai, Senzo Taguchi, Naoko Asano, Fumihiro Ishida, Motoko Yamaguchi, Ritsuro Suzuki

Blood (2024) 144 (Supplement 1): 1682.

https://doi.org/10.1182/blood-2024-205065

Published: 2024

Journal Articles

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2023) 142 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2023-174647

Published: 2023

Journal Articles

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2022) 140 (Supplement 1): 11890–11892.

https://doi.org/10.1182/blood-2022-164977

Published: 2022

Journal Articles

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Blood (2021) 138 (Supplement 1): 2451.

https://doi.org/10.1182/blood-2021-146340

Published: 2021

Journal Articles

Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

Kana Miyazaki, MD PhD, Senzo Taguchi, MD PhD, Masahiko Oguchi, MD PhD, Ritsuro Suzuki, MD PhD, Naoko Asano, MD PhD, Yasuhito Terui, MD PhD, Nobuko Kubota, MD PhD, Yoshihiro Saito, MD PhD, Takeshi Maeda, MD, Satoshi Itasaka, MD, Yukio Kobayashi, MD DSc, Jun Itami, MD PhD, Jun Amaki, MD PhD, Takeshi Akiba, MD PhD, Tohru Murayama, MD PhD, Noriko Ii, MD PhD, Toshinori Soejima, MD PhD, Motoko Yamaguchi, MD PhD, Naoyuki Katayama, MD PhD

Blood (2018) 132 (Supplement 1): 2935.

https://doi.org/10.1182/blood-2018-99-115546

Published: 2018

Journal Articles

In Situ Hybridization of HBZ and Tax in FFPE Samples from ATLL Patients and Its Association with Clinicopathological Characteristics

Kyohei Yamada, MD, Hiroaki Miyoshi, MD PhD, Mai Takeuchi, MD PhD, Naoko Asano, MD PhD, Joji Shimono, MD PhD, Fumiko Arakawa, PhD, Kazutaka Nakashima, Kensaku Sato, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD

Blood (2018) 132 (Supplement 1): 1643.

https://doi.org/10.1182/blood-2018-99-112082

Published: 2018

Journal Articles

Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study

Blood (2017) 130 (Supplement 1): 1518.

https://doi.org/10.1182/blood.V130.Suppl_1.1518.1518

Published: 2017

Journal Articles

Limited-Stage Mantle Cell Lymphoma

Ritsuro Suzuki, MD PhD, Dai Chihara, MD PhD, Naoko Asano, MD PhD, Ken Ohmachi, MD, Tomohiro Kinoshita, MD PhD, Kosei Matsue, MD PhD, Junji Suzumiya, MD PhD, Michinori Ogura

Blood (2016) 128 (22): 5330.

https://doi.org/10.1182/blood.V128.22.5330.5330

Published: 2016

Journal Articles

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Naoko Asano, MD PhD, Hiroaki Miyoshi, MD PhD, Takeharu Kato, MD, Joji Shimono, MD, Noriaki Yoshida, MD PhD, Daisuke Kurita, MD, Yuya Sasaki, MD, Keisuke Kawamoto, MD, Koichi Ohshima, MD PhD, Masao Seto, MD PhD

Blood (2016) 128 (22): 4135.

https://doi.org/10.1182/blood.V128.22.4135.4135

Published: 2016

Journal Articles

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Blood (2016) 128 (22): 3029.

https://doi.org/10.1182/blood.V128.22.3029.3029

Published: 2016

Journal Articles

Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 89 BL Patients in Japan

Akira Satou, MD PhD, Naoko Asano, MD PhD, Seiichi Kato, MD PhD, Ahmed Ali Elsayed, MD, Naoya Nakamura, MD PhD, Koichi Ohshima, MD PhD, Shigeo Nakamura, MD PhD

Blood (2015) 126 (23): 3886.

https://doi.org/10.1182/blood.V126.23.3886.3886

Published: 2015

Journal Articles

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Dai Chihara, MD PhD, Naoko Asano, MD PhD, Ohmachi Ken, Momoko Nishikori, MD, PhD, Masataka Okamoto, Masashi Sawa, Rika Sakai, MD PhD, Yasushi Okoshi, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihiro Yakushijin, MDPhD, Shigeo Nakamura, MD PhD, Tomohiro Kinoshita, Michinori Ogura, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2014) 124 (21): 1660.

https://doi.org/10.1182/blood.V124.21.1660.1660

Published: 2014

Journal Articles

Simplified MIPI Is a Valid Prognostic Index In The Rituximab Era: Multicenter MCL Study In Japan

Dai Chihara, MD, PhD, Naoko Asano, MD, Ph.D., Tomohiro Kinoshita, MD, PhD, Yoshinobu Maeda, MD, PhD, Kosei Matsue, MD, PhD, Ken Ohmachi, M.D., Masataka Okamoto, MD, PhD, Ishikazu Mizuno, MD, Toshiki Uchida, MD, PhD, Hirokazu Nagai, MD, PhD, Michinori Ogura, M.D., Ph.D., Ritsuro Suzuki, MD

Blood (2013) 122 (21): 4257.

https://doi.org/10.1182/blood.V122.21.4257.4257

Published: 2013

Journal Articles

Rituximab Sensitivity to De Novo DLBCL Cells Showing the Specific Phenotype of CD20 Protein Immunohistochemistry-Positive / Flow Cytometory-Negative: Analyses of Its Clinical Significances and the Molecular Mechanisms.

Akihiro Tomita, MD, Ph.D., Takashi Tokunaga, MD, Tatsuya Hirose, Keiki Sugimoto, Kazuyuki Shimada, MD, Ph.D., Norio Kaneda, MD, Ph.D., Hitoshi Kiyoi, MD, PhD, Naoko Asano, MD, Ph.D., Shigeo Nakamura, M.D., Ph.D., Tomohiro Kinoshita, M.D., Ph.D., Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 2682.

https://doi.org/10.1182/blood.V120.21.2682.2682

Published: 2012

Journal Articles

Anaplastic Variant of Diffuse Large B-Cell Lymphoma: Re-Apprasial As Extra-Mediastinal Grey Zone Lymphoma Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma,

Nirmeen Ali Megahed, M.Sc., Seiichi Kato, Naoko Asano, MD, Shigeo Nakamura, MD, PhD

Blood (2011) 118 (21): 3660.

https://doi.org/10.1182/blood.V118.21.3660.3660

Published: 2011

Journal Articles

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Nodoka Sekiguchi, MD, Naoko Asano, MD, Hideki Makishima, MD, PhD, Masanobu Momose, MT, Toshiro Ito, MD, Shigeo Nakamura, MD, Fumihiro Ishida, MD

Blood (2010) 116 (21): 4140.

https://doi.org/10.1182/blood.V116.21.4140.4140

Published: 2010

Journal Articles

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Naoko Asano, MD, Tomohiro Kinoshita, MD, PhD, Koichi Ohshima, MD, Tadashi Yoshino, MD, Nozomi Niitsu, MD, Norifumi Tsukamoto, MD, PhD, Kaoru Hirabayashi, MD, Koji Izutsu, MD, Yasuo Morishima, MD, PhD, Tadashi Matsushita, MD, PhD, Shigeo Nakamura, MD

Blood (2010) 116 (21): 2677.

https://doi.org/10.1182/blood.V116.21.2677.2677

Published: 2010

Journal Articles

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Naoko Asano, MD, PhD, Jun-Ichi Tamaru, MD, PhD, Fumihiro Ishida, MD, PhD, Tadashi Yoshino, MD, PhD, Yoshitoyo Kagami, MD, PhD, Yasuo Morishima, MD, PhD, Masao Seto, MD, PhD, Tomohiro Kinoshita, MD, PhD, Shigeo Nakamura, MD, PhD

Blood (2009) 114 (22): 1549.

https://doi.org/10.1182/blood.V114.22.1549.1549

Published: 2009

NARROW

Treatment and Outcomes of Stage I-II Pulmonary MALT Lymphoma: A Multi-Institutional Observational Study in Japan

Number of Sites of Involvement Predicts Central Nervous System Relapse in Patients with Localized Extranodal Natural Killer/T-Cell Lymphoma

Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)

Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study)

Incidence and Risk Factors of Central Nervous System Relapse in Localized Extranodal NK/T-Cell Lymphoma, Nasal Type: An Analysis of Nkea Study

In Situ Hybridization of HBZ and Tax in FFPE Samples from ATLL Patients and Its Association with Clinicopathological Characteristics

Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study

Limited-Stage Mantle Cell Lymphoma

Expression Pattern of Immunosurveillance-Related Antigen Is a Critical Prognostic Factor of Adult T-Cell Leukemia/Lymphoma

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 89 BL Patients in Japan

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Simplified MIPI Is a Valid Prognostic Index In The Rituximab Era: Multicenter MCL Study In Japan

Rituximab Sensitivity to De Novo DLBCL Cells Showing the Specific Phenotype of CD20 Protein Immunohistochemistry-Positive / Flow Cytometory-Negative: Analyses of Its Clinical Significances and the Molecular Mechanisms.

Anaplastic Variant of Diffuse Large B-Cell Lymphoma: Re-Apprasial As Extra-Mediastinal Grey Zone Lymphoma Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma,

Profiles of Cytotoxic Molecules In Mature NK Cell Neoplasms

Clinicopathological Features of Nodular Sclerosis-Type Classical Hodgkin Lymphoma In the Elderly: Multicenter Study of Hodgkin Lymphoma In Japan

Cytotoxic Molecule (CM)-Positive Classical Hodgkin Lymphoma: a Clinicopathologic Study in Comparison with Nodal Peripheral T-Cell Lymphoma of Not Otherwise Specified Type Possessing CM Expression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only